-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Biomarin Pharmaceutical Inc annual Current Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc annual Current Income Tax Expense (Benefit) for 2023 was $65.9 M, a 9.65% increase from 2022.
- Biomarin Pharmaceutical Inc annual Current Income Tax Expense (Benefit) for 2022 was $60.1 M, a 1285% increase from 2021.
- Biomarin Pharmaceutical Inc annual Current Income Tax Expense (Benefit) for 2021 was $4.34 M.
Current Income Tax Expense (Benefit), Annual Data (USD)